Jacques E. Chelly
11
2
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
9.1%
1 terminated/withdrawn out of 11 trials
85.7%
-0.8% vs industry average
0%
0 trials in Phase 3/4
100%
6 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
Role: lead
Auriculotherapy in the Treatment of Pre-Operative Anxiety
Role: lead
Transition From Acute to Chronic Opioid Use and Chronic Pain
Role: lead
NEUROCUPLE™ as an Opioid Alternative Following Total Knee Arthroplasty
Role: lead
Vagal Stimulator to Reduce Nasogastric Tube Use
Role: lead
A Pilot Study Investigating the nCAP Signal Relief Patch in Subjects Undergoing Primary Hip or Knee Replacement Surgery
Role: lead
Perioperative Ketamine in Opioid-Tolerant Patients Undergoing Lumbar Spine Surgery
Role: lead
NSS-2-BRIDGE Study for Total Knee and Hip Arthroplasties, Bariatric, and Kidney Transplant Surgeries
Role: lead
Auriculotherapy for Surgical Pain
Role: lead
NSS-2 BRIDGE Device in Post-Operative Pain Management
Role: lead
A Pain Study Comparing Two Commonly Used Medications to Treat Pain After Bowel Surgery
Role: lead
All 11 trials loaded